ACS Medicinal Chemistry Letters · 2012 · 111 citations · 17 references
Life SciencesChemical BiologyImmunologyInflammationInnate ImmunitySignal TransductionCell-penetrating PeptidesInflammatory Cell ResponsesInflammatory Cell SignalingInflammatory Response RegulationInflammatory SignalingReactive Oxygen SpeciesAnti-inflammatory Signaling PathwaysAnti-inflammatory TherapeuticsInflammatory Cytokine SecretionInflammatory Mediator PathwaysNrf2 Pathway ActivationNrf2 Signaling PathwayPro-inflammatory Cytokine ExpressionPro-inflammatory Signaling Pathways
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is increasingly recognized as a central regulator of multiple signaling pathways in inflammation and cancer, and the ability to use chemical biological tools to investigate its biological effects is very attractive. A peptide comprising a TAT-conjugated Nrf2 sequence is shown to activate Nrf2 and its downstream target gene heme-oxygenase-1 (HO-1) in a dose-dependent manner in intact human THP-1 monocytes. Levels of Nrf2 protein peak after 3 h, whereas HO-1 mRNA and protein peak after 6 and 12 h, respectively. The peptide is also shown to inhibit the production of the pro-inflammatory cytokine TNF. The TAT-14mer constitutes a useful chemical biology tool with potential therapeutic applications.
17
Ken Itoh, Tomoki Chiba, Satoru Takahashi et al. · Biochemical and Biophysical Research Communications · 1997 · 4K citations
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Steven R. Schwarze, Alan L. Ho, Adamina Vocero-Akbani et al. · Science · 1999 · 2.4K citations
Paolo Moi, Isadora Asunis, Antonio Cao et al. · Proceedings of the National Academy of Sciences · 1994 · 1.6K citations